APYX / Apyx Medical Corporation - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Apyx Medical Corporation
US ˙ NasdaqGS ˙ US03837C1062

Deler fremragende 41,829,226 shares
Insideraktier11.478.305 shares
Insider ejerskab27,44 %
Total Insiders26
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
9012 out of 10916

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
5330 out of 10752

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Apyx Medical Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Corp Acmi 10% Owner - [10%] 0 0
Andres John C. 17.000
Minnie Baylor-Henry 17.000
Moshe Citronowicz Senior Vice President - [O] 493.504 493.504
Scott Richard Davidson Director - [D] 5.360.000 5.360.000
Ewers Jay D. 30.000
Michael Geraghty Director - [D] 27.500 27.500
Robert Gershon Chief Executive Officer, Director - [D] [O] 30.000 30.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Goodwin Charles D. II Chief Executive Officer, Director - [D] [O] 90.000 90.000
Matthew C Hill Chief Financial Officer - [O] 8.500 8.500
Todd Hornsby Executive Vice President - [O] 0 0
George W Kromer Director - [D] 247.508 247.508
August Lentricchia 57.500
Andrew Makrides Director - [D] 624.389 624.389
Medical Wind Down Holdings I Inc 10% Owner - [10%] 0 0
McCarthy John J. III Chief CommercializationOfficer - [O] 115.750 115.750
Michael G Norman 135.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Orsatti Charles T. 12.000
Gary Pickett 57.500
Shawn David Roman Chief Operating Officer - [O] 12.000 12.000
J Robert Saron President, Director - [D] [O] 393.698 393.698
Tara Semb 96.000
Ian Sheffield Director - [D] 480.000 480.000
Swandal Craig A. Director - [D] 60.173 60.173
Vizirgianakis Stavros G. Director - [D] 3.492.382 3.492.382
Lawrence Waldman Director - [D] 42.901 42.901

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i APYX / Apyx Medical Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-08-13 HILL MATTHEW C 5.336 1,1300 5.336 1,1300 6.030 328 2.5800 7.738 128,34
2024-08-13 HILL MATTHEW C 6.000 1,1300 6.000 1,1300 6.780
2023-12-12 HILL MATTHEW C 2.500 2,1900 2.500 2,1900 5.475
2023-11-14 Goodwin Charles D. II 50.000 1,5700 50.000 1,5700 78.500
2022-08-29 Goodwin Charles D. II 2.000 5,9300 2.000 5,9300 11.860
2022-08-29 Goodwin Charles D. II 9.750 5,9700 9.750 5,9700 58.208
2020-05-13 Goodwin Charles D. II 28.250 3,2990 28.250 3,2990 93.197
2016-08-17 McCarthy John J. III 90.750 3,3000 90.750 3,3000 299.475
2015-12-22 McCarthy John J. III 25.000 1,9771 25.000 1,9771 49.428

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APYX / Apyx Medical Corporation Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i APYX / Apyx Medical Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APYX / Apyx Medical Corporation Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-17 2026-03-15 4 CITRONOWICZ MOSHE APYX Common Stock M - Exercise D 1,8000 37.000 67 493.504
2026-01-29 2026-01-27 4 Roman Shawn David By The Roman Family Revocable Trust APYX Common Stock M - Exercise I 1,8000 12.000 22 12.000
2025-03-03 2024-08-13 4/A HILL MATTHEW C APYX Common Stock P - Purchase D 1,1300 6.000 7 8.500
2024-08-13 2024-08-13 4 HILL MATTHEW C APYX Common Stock P - Purchase D 1,1300 5.336 6 7.836
2024-05-09 3 Vizirgianakis Stavros G. APYX Common Stock D 1.746.191
2023-12-14 2023-12-12 4 HILL MATTHEW C APYX Common Stock P - Purchase D 2,1900 2.500 5 2.500
2023-11-15 2023-11-14 4 Goodwin Charles D. II APYX Common Stock P - Purchase D 1,5700 50.000 78 90.000
2023-07-19 2023-07-12 4 Waldman Lawrence By SLAT APYX Common Stock M - Exercise I 2,9700 5.338 16 5.338
2023-06-29 2023-06-26 4/A Hornsby Todd APYX Common Stock S - Sale D 7,5600 -15.000 -113 0
2023-06-29 2023-06-26 4/A Hornsby Todd APYX Common Stock M - Exercise D 1,7700 15.000 27 15.000
2023-06-28 2023-06-26 4 Hornsby Todd APYX Common Stock S - Sale D 7,5600 -15.000 -113 40
2023-06-28 2023-06-26 4 Hornsby Todd APYX Common Stock M - Exercise D 1,7700 15.000 27 15.000
2023-06-09 2023-06-06 4 Geraghty Michael APYX Common Stock M - Exercise D 2,7900 10.000 28 27.500
2023-03-22 2022-01-07 4 Swandal Craig A. APYX Common Stock M - Exercise D 9,4200 7.173 68 60.173
2022-08-31 2022-08-29 4 Goodwin Charles D. II APYX Common Stock P - Purchase D 5,9700 9.750 58 40.000
2022-08-31 2022-08-29 4 Goodwin Charles D. II APYX Common Stock P - Purchase D 5,9300 2.000 12 30.250
2022-07-12 2022-07-11 4 CITRONOWICZ MOSHE APYX Common Stock M - Exercise D 2,5400 30.000 76 456.504
2022-07-11 2022-07-11 4 Waldman Lawrence APYX Common Stock M - Exercise D 2,5400 24.000 61 37.563
2022-07-11 2022-07-05 4 MAKRIDES ANDREW APYX Common Stock F - Taxes D 6,1400 -13.583 -83 624.389
2022-07-11 2022-07-05 4 MAKRIDES ANDREW APYX Common Stock M - Exercise D 2,5400 30.000 76 637.972
2022-07-11 2022-07-06 4 Geraghty Michael APYX Common Stock M - Exercise D 2,5400 4.000 10 17.500
2022-05-23 2022-05-19 4 Waldman Lawrence APYX Stock Option (Option to Buy) M - Exercise D 2,79 -8.000 0
2022-05-23 2022-05-19 4 Waldman Lawrence APYX Common Stock M - Exercise D 2,7900 8.000 22 13.563
2022-05-19 2022-05-11 4 Geraghty Michael APYX Stock Option (Option to Buy) M - Exercise D 2,79 -6.000 0
2022-05-19 2022-05-11 4 Geraghty Michael APYX Common Stock M - Exercise D 2,7900 6.000 17 13.500
2022-03-22 2022-03-21 4 Swandal Craig A. APYX Stock Option (Option to Buy) M - Exercise D 4,98 -17.000 0
2022-03-22 2022-03-21 4 Swandal Craig A. APYX Common Stock M - Exercise D 4,9800 17.000 85 17.000
2022-02-01 2022-01-19 4 Hornsby Todd APYX Stock Option (Option to Buy) A - Award D 10,96 100.000 100.000
2022-02-01 2022-01-19 4 CITRONOWICZ MOSHE APYX Stock Option (Option to Buy) A - Award D 10,96 72.000 72.000
2022-01-31 2022-01-19 4 Goodwin Charles D. II APYX Stock Option (Option to Buy) A - Award D 10,96 243.000 243.000
2022-01-31 2022-01-19 4 Semb Tara APYX Stock Option (Option to Buy) A - Award D 10,96 96.000 96.000
2021-08-11 2021-08-06 4 Baylor-Henry Minnie APYX Stock Option (Option to Buy) A - Award D 9,42 17.000 17.000
2021-08-11 2021-08-06 4 Swandal Craig A. APYX Stock Option (Option to Buy) A - Award D 9,42 17.000 17.000
2021-08-11 2021-08-06 4 Geraghty Michael APYX Stock Option (Option to Buy) A - Award D 9,42 17.000 17.000
2021-08-11 2021-08-06 4 MAKRIDES ANDREW APYX Stock Option (Option to Buy) A - Award D 9,42 17.000 17.000
2021-08-11 2021-08-06 4 Andres John C. APYX Stock Option (Option to Buy) A - Award D 9,42 17.000 17.000
2021-08-11 2021-08-06 4 Waldman Lawrence APYX Stock Option (Option to Buy) A - Award D 9,42 17.000 17.000
2021-03-08 2021-03-08 4 Waldman Lawrence APYX Stock Option (Option to Buy) X - Other D 2,81 2,8100 -7.500 -21 0
2021-03-08 2021-03-08 4 Waldman Lawrence APYX Common Stock M - Exercise D 2,8100 5.563 16 5.563
2021-03-08 2021-03-05 4 Geraghty Michael APYX Stock Option (Option to Buy) X - Other D 2,81 2,8100 -7.500 -21 0
2021-03-08 2021-03-05 4 Geraghty Michael APYX Common Stock M - Exercise D 2,8100 7.500 21 7.500
2021-02-12 2020-10-07 5 Swandal Craig A. APYX Stock Option (Option to Buy) M - Exercise D 7,28 7,2800 -7.084 -52 0
2021-02-12 2020-10-07 5 Swandal Craig A. APYX Common Stock M - Exercise D 7,2800 7.084 52 17.000
2021-02-12 2020-03-04 5 Swandal Craig A. APYX Stock Option (Option to Buy) M - Exercise D 7,28 7,2800 -9.916 -72 0
2021-02-12 2020-03-04 5 Swandal Craig A. APYX Common Stock M - Exercise D 7,2800 9.916 72 17.000
2021-02-12 2020-08-06 5 Waldman Lawrence APYX Stock Option (Option to Buy) A - Award D 4,98 4,9800 17.000 85 17.000
2021-02-10 2021-01-29 4 CITRONOWICZ MOSHE APYX Stock Option (Option to Buy) A - Award D 9,29 36.000 36.000
2021-02-09 2021-01-29 4 Hornsby Todd APYX Stock Option (Option to Buy) A - Award D 9,29 50.000 50.000
2021-02-09 2021-01-29 4 Goodwin Charles D. II APYX Common Stock A - Award D 9,29 121.500 121.500
2021-02-09 2021-01-29 4 Semb Tara APYX Stock Option (Option to Buy) A - Award D 9,29 48.000 48.000
2020-08-10 2020-08-06 4 MAKRIDES ANDREW APYX Stock Option (Option to Buy) A - Award D 4,98 4,9800 17.000 85 17.000
2020-08-10 2020-08-06 4 Swandal Craig A. APYX Stock Option (Option to Buy) A - Award D 4,98 4,9800 17.000 85 17.000
2020-08-10 2020-08-06 4 Andres John C. APYX Stock Option (Option to Buy) A - Award D 4,98 4,9800 17.000 85 17.000
2020-08-10 2020-08-06 4 Baylor-Henry Minnie APYX Stock Option (Option to Buy) A - Award D 4,98 4,9800 17.000 85 17.000
2020-08-10 2020-08-06 4 Geraghty Michael APYX Stock Option (Option to Buy) A - Award D 4,98 4,9800 17.000 85 17.000
2020-05-14 2020-05-13 4 Goodwin Charles D. II APYX Common Stock P - Purchase D 3,2990 28.250 93 28.250
2020-03-05 2019-10-01 4 Swandal Craig A. APYX Stock Option (Option to Buy) X - Other D 5,30 5,3000 -10.000 -53 0
2020-03-05 2019-10-01 4 Swandal Craig A. APYX Common Stock X - Other D 5,3000 10.000 53 36.000
2020-03-05 2019-01-10 4 Swandal Craig A. APYX Stock Option (Option to Buy) X - Other D 5,30 5,3000 -8.000 -42 16.000
2020-03-05 2019-01-10 4 Swandal Craig A. APYX Stock Option (Option to Buy) X - Other D 2,37 2,3700 -10.000 -24 2.000
2020-03-05 2019-01-10 4 Swandal Craig A. APYX Common Stock X - Other D 5,3000 8.000 42 18.000
2020-03-05 2019-01-10 4 Swandal Craig A. APYX Common Stock X - Other D 2,3700 10.000 24 10.000
2020-03-05 2019-04-04 4 Swandal Craig A. APYX Stock Option (Option to Buy) O - Other D 5,30 5,3000 -6.000 -32 10.000
2020-03-05 2019-04-04 4 Swandal Craig A. APYX Stock Option (Option to Buy) X - Other D 2,37 2,3700 -2.000 -5 0
2020-03-05 2019-04-04 4 Swandal Craig A. APYX Common Stock O - Other D 5,3000 6.000 32 26.000
2020-03-05 2019-04-04 4 Swandal Craig A. APYX Common Stock X - Other D 2,3700 2.000 5 20.000
2020-01-22 2020-01-15 4 CITRONOWICZ MOSHE APYX Stock Option (Option to Buy) A - Award D 8,18 72.000 72.000
2020-01-22 2020-01-15 4 Semb Tara APYX Stock Option (Option to Buy) A - Award D 8,18 96.000 96.000
2020-01-22 2020-01-15 4 Goodwin Charles D. II APYX Stock Option (Option to Buy) A - Award D 8,18 243.000 243.000
2020-01-22 2020-01-15 4 Hornsby Todd APYX Stock Option (Option to Buy) A - Award D 8,18 100.000 100.000
2019-08-05 2019-08-01 4 MAKRIDES ANDREW APYX Stock Option (Option to Buy) A - Award D 7,28 17.000 17.000
2019-08-05 2019-08-01 4 Geraghty Michael APYX Stock Option (Option to Buy) A - Award D 7,28 17.000 17.000
2019-08-05 2019-08-01 4 Waldman Lawrence APYX Stock Option (Option to Buy) A - Award D 7,28 17.000 17.000
2019-08-05 2019-08-01 4 Andres John C. APYX Stock Option (Option to Buy) A - Award D 7,28 17.000 17.000
2019-08-05 2019-08-01 4 Swandal Craig A. APYX Stock Option (Option to Buy) A - Award D 7,28 17.000 17.000
2019-02-11 2019-01-09 4 CITRONOWICZ MOSHE APYX Stock Option (Option to Buy) A - Award D 7,91 72.000 72.000
2019-02-11 2019-01-09 4 Hornsby Todd APYX Stock Option (Option to Buy) A - Award D 7,91 76.000 76.000
2019-02-11 2019-01-09 4 Goodwin Charles D. II APYX Stock Option (Option to Buy) A - Award D 7,91 236.000 236.000
2019-02-11 2019-01-09 4 Semb Tara APYX Stock Option (Option to Buy) A - Award D 7,91 65.000 65.000
2019-01-15 3 Hornsby Todd APYX Common Stock D 80
2019-01-15 3 Hornsby Todd APYX Common Stock D 80
2019-01-15 3 Hornsby Todd APYX Common Stock D 80
2018-11-09 2018-11-08 4 MAKRIDES ANDREW BVX Common Stock G - Gift D 6,8400 -2.000 -14 605.972
2018-11-09 2018-11-08 4 MAKRIDES ANDREW BVX Common Stock G - Gift D 6,8400 -2.000 -14 605.972
2018-11-09 2018-11-08 4 MAKRIDES ANDREW BVX Common Stock G - Gift D 6,8400 -2.000 -14 605.972
2018-09-10 2018-08-30 4 Swandal Craig A. BVX Stock Option (Option to Buy) A - Award D 5,30 24.000 24.000
2018-09-10 2018-08-30 4 Andres John C. BVX Stock Option (Option to Buy) A - Award D 5,30 24.000 24.000
2018-09-10 2018-08-30 4 Geraghty Michael BVX Stock Option (Option to Buy) A - Award D 5,30 24.000 24.000
2018-09-10 2018-08-30 4 MAKRIDES ANDREW BVX Stock Option (Option to Buy) A - Award D 5,30 12.000 12.000
2018-09-10 2018-08-30 4 Waldman Lawrence BVX Stock Option (Option to Buy) A - Award D 5,30 24.000 24.000
2018-01-11 2018-01-04 4 Ewers Jay D. BVX Stock Option (Option to Buy) A - Award D 2,59 30.000 30.000
2017-09-27 2017-05-01 4 CITRONOWICZ MOSHE BVX Stock Option (Option to Buy) A - Award D 3,23 70.000 70.000
2017-09-27 2017-05-01 4 Gershon Robert BVX Stock Option (Option to Buy) A - Award D 3,23 100.000 100.000
2017-09-27 2017-09-14 4 Andres John C. BVX Stock Option (Option to Buy) A - Award D 2,85 12.000 12.000
2017-09-27 2017-09-14 4 Geraghty Michael BVX Stock Option (Option to Buy) A - Award D 2,85 12.000 12.000
2017-09-27 2017-09-14 4 Waldman Lawrence BVX Stock Option (Option to Buy) A - Award D 2,85 12.000 12.000
2017-09-27 2017-09-14 4 MAKRIDES ANDREW BVX Stock Option (Option to Buy) A - Award D 2,85 12.000 12.000
2017-09-27 2017-05-01 4 McCarthy John J. III BVX Stock Option (Option to Buy) A - Award D 3,23 70.000 70.000
2017-09-27 2017-05-01 4 SARON J ROBERT BVX Stock Option (Option to Buy) A - Award D 3,23 70.000 70.000
2017-09-27 2017-05-01 4 Ewers Jay D. BVX Stock Option (Option to Buy) A - Award D 3,23 70.000 70.000
2016-08-19 2016-08-17 4 McCarthy John J. III BVX Common Stock P - Purchase D 3,3000 90.750 299 115.750
2016-08-08 3 Davidson Scott Richard BVX Common Stock I 5.360.000
2016-08-08 3 Davidson Scott Richard BVX Common Stock I 5.360.000
2016-08-04 2016-07-28 4/A Andres John C. BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-04 2016-07-28 4/A Orsatti Charles T. BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-04 2016-07-28 4/A Geraghty Michael BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-04 2016-07-28 4/A Waldman Lawrence BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-03 2016-07-28 4 Andres John C. BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-03 2016-07-28 4 Geraghty Michael BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-03 2016-07-28 4 Orsatti Charles T. BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-03 2016-07-28 4 Waldman Lawrence BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2016-08-03 2016-07-28 4 Orsatti Charles T. BVX Stock Option (Option to Buy) A - Award D 1,88 12.000 12.000
2015-12-23 2015-12-21 4 Gershon Robert BVX Common Stock P - Purchase D 1,8168 10.000 18 30.000
2015-12-23 2015-12-21 4 CITRONOWICZ MOSHE BVX Common Stock P - Purchase D 1,8387 20.000 37 426.504
2015-12-23 2015-12-22 4 McCarthy John J. III BVX Common Stock P - Purchase D 1,9771 25.000 49 25.000
2015-10-21 2015-10-14 4 Ewers Jay D. BVX Stock Option (Option to Buy) A - Award D 2,13 65.000 65.000
2015-08-17 2015-08-14 4 Gershon Robert BVX Common Stock P - Purchase D 2,3900 20.000 48 20.000
2015-08-07 2015-07-16 4 Geraghty Michael BVX Stock Option (Option to Buy) A - Award D 2,30 12.500 12.500
2015-08-07 2015-07-16 4 Orsatti Charles T. BVX Stock Option (Option to Buy) A - Award D 2,30 12.500 12.500
2015-08-07 2015-07-16 4 Waldman Lawrence BVX Stock Option (Option to Buy) A - Award D 2,30 12.500 12.500
2015-08-07 2015-07-16 4 Andres John C. BVX Stock Option (Option to Buy) A - Award D 2,30 12.500 12.500
2015-03-18 2015-03-17 4 Sheffield Ian See Footnote 1 BVX Common Stock Warrants (right to buy) D - Sale to Issuer I 5.250.000 0
2015-03-18 2015-03-17 4 Sheffield Ian See Footnote 1 BVX Series A Convertible Preferred Stock D - Sale to Issuer I 3.500.000 0
2015-03-18 2015-03-17 4 Sheffield Ian See Footnote 1 BVX Series B Convertible Preferred Stock A - Award I 3.588.139 3.588.139
2015-03-18 2015-03-17 4 Sheffield Ian See footnote 1 BVX Common Stock A - Award I 2,5000 480.000 1.200 480.000
2014-09-23 2014-09-19 4 MAKRIDES ANDREW BVX Stock Option (Option to Buy) M - Exercise D 2,13 12.759 0
2014-09-23 2014-09-19 4 MAKRIDES ANDREW BVX Common Stock F - Taxes D 4,3500 -12.241 -53 611.972
2014-09-23 2014-09-19 4 MAKRIDES ANDREW BVX Common Stock M - Exercise D 2,1300 25.000 53 624.213
2014-09-23 2014-09-19 4 SARON J ROBERT BVX Common Stock F - Taxes D 4,3500 6.121 27 393.698
2014-09-23 2014-09-19 4 SARON J ROBERT BVX Common Stock M - Exercise D 2,1300 12.500 27 399.819
2014-09-23 2014-09-18 4 SARON J ROBERT BVX Stock Option (Option to Buy) M - Exercise D 2,13 6.379 12.500
2014-09-15 2014-07-17 4 Sheffield Ian BVX Stock Option (Option to Buy) A - Award D 3,81 12.000 12.000
2014-09-11 2014-07-17 4 Waldman Lawrence BVX Stock Option (Option to Buy) A - Award D 3,81 12.000 12.000
2014-09-10 2014-07-17 4 Geraghty Michael BVX Stock Option (Option to Buy) A - Award D 3,81 10.000 10.000
2014-02-03 2013-12-09 4 Norman Michael G bvx Stock options A - Award D 2,20 10.000 135.000
2014-01-30 2013-12-09 4 Lentricchia August bvx Stocks options A - Award D 2,20 10.000 57.500
2014-01-29 2013-12-09 4 Waldman Lawrence bvx Stock options A - Award D 2,20 25.000 76.500
2013-10-04 2013-10-01 4 KROMER GEORGE W bvx Common stock G - Gift D 2,9100 -4.000 -12 247.508
2013-08-14 2013-07-16 4 Norman Michael G bvx Stock options A - Award D 2,97 10.000 125.000
2013-08-14 2013-07-16 4 Geraghty Michael bvx Stock options A - Award D 2,97 10.000 27.500
2013-08-14 2013-07-16 4 Waldman Lawrence bvx Stock options A - Award D 2,97 12.000 51.500
2013-08-13 2013-07-16 4 Lentricchia August bvx Stock options A - Award D 2,97 10.000 43.500
2012-12-10 2012-12-05 4 KROMER GEORGE W bvx Common stock G - Gift D 2,6500 -5.000 -13 251.508
2012-09-20 2012-09-06 4 KROMER GEORGE W bvx Common stock G - Gift D 2,6600 -5.000 -13 256.508
2012-07-19 2012-07-12 4 KROMER GEORGE W bvx Stock options A - Award D 2,54 25.000 100.000
2012-07-19 2012-07-12 4 MAKRIDES ANDREW bvx Stock options A - Award D 2,54 30.000 105.000
2012-07-19 2012-07-12 4 CITRONOWICZ MOSHE bvx Stock options A - Award D 2,54 30.000 30.000
2012-07-19 2012-07-12 4 SARON J ROBERT bvx Stock options A - Award D 2,54 30.000 67.500
2012-07-19 2012-07-12 4 Norman Michael G bvx Stock options A - Award D 2,54 4.000 115.000
2012-07-19 2012-07-12 4 Pickett Gary bvx Stock options A - Award D 2,54 10.000 57.500
2012-07-19 2012-07-12 4 Geraghty Michael bvx Stock options A - Award D 2,54 4.000 17.500
2012-07-18 2012-07-12 4 Lentricchia August bvx Stock options A - Award D 2,54 4.000 37.500
2012-07-18 2012-07-12 4 Waldman Lawrence bvx Stock options A - Award D 2,54 24.000 39.500
2012-05-22 2012-05-21 4 Lentricchia August bvx Stock options A - Award D 2,79 6.000 33.500
2012-05-22 2012-05-21 4 Norman Michael G bvx Stock options A - Award D 2,79 6.000 111.000
2012-05-22 2012-05-21 4 Geraghty Michael bvx Stock options A - Award D 2,79 6.000 13.500
2012-05-22 2012-05-21 4 Waldman Lawrence bvx Stock options A - Award D 2,79 8.000 15.500
2004-09-28 2004-09-24 4 ACMI CORP BVX Common Stock P - Purchase D 1,7500 -3.000.000 -5.250 0
2004-07-22 3 ACMI CORP BVX Common Stock D 3.000.000
2004-05-25 2004-05-21 4 MEDICAL WIND DOWN HOLDINGS I INC BVX Common Stock J - Other D -3.000.000 0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:BOV 3,24 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista